The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy

Journal of Ethnopharmacology

Volumn 137, Issue 3, 2011, Pages 1409-1414

  Lee, Sang Hun ^a   Kim, Young Seok ^a   Lee, Seung Jin ^a   Lee, Byung Cheol ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Advanced glycation end product; Collagen IV; Diabetic nephropathy; Receptor of advanced glycation end products; Renoprotection; Salvia miltiorrhiza; Transforming growth factor 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; COLLAGEN TYPE 4; GLUCOSE; SALVIA MILTIORRHIZA EXTRACT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXPERIMENTAL MODEL; GLUCOSE BLOOD LEVEL; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; URINARY EXCRETION;

ANIMALS; BLOOD GLUCOSE; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DRUGS, CHINESE HERBAL; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; MACROPHAGES; MALE; MONOCYTES; PROTECTIVE AGENTS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; SALVIA MILTIORRHIZA; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; RATTUS; SALVIA MILTIORRHIZA;

EID: 80054878078     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.08.007     Document Type: Article

References (31)

1. Y.M. Ahn, S.K. Kim, S.H. Lee, S.Y. Ahn, S.W. Kang, J.H. Chung, S.D. Kim, and B.C. Lee Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease Phytotherapy Research 24 2010 1886 1892
2. J. Allard, M. Buleon, E. Cellier, I. Renaud, C. Pecher, F. Praddaude, M. Conti, I. Tack, and J.P. Girolami ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats American Journal of Physiology. Renal Physiology 293 2007 F1083 F1092
3. M.E. Cooper Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy Diabetologia 44 2001 1957 1972
4. J.S. Duffield The inflammatory macrophage: a story of Jekyll and Hyde Clinical Science (London) 104 2003 27 38
5. J.L. Figarola, S. Scott, S. Loera, B. Xi, T. Synold, and S. Rahbar Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats Annals of the New York Academy of Sciences 1043 2005 767 776
6. H. Ha, M.R. Yu, and H.B. Lee High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells Kidney International 59 2001 463 470
7. S.I. Jang, S.I. Jeong, K.J. Kim, H.J. Kim, H.H. Yu, R. Park, H.M. Kim, and Y.O. You Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha IL-1beta and IL-6 in activated RAW 264. 7 cells Planta Medica 69 2003 1057 1059
8. S.H. Jung, H.J. Seol, S.J. Jeon, K.H. Son, and J.R. Lee Insulin-sensitizing activities of tanshinones, diterpene compounds of the root of Salvia miltiorrhiza Bunge Phytomedicine 16 2009 327 335
9. D.D. Kim, F.A. Sanchez, R.G. Duran, T. Kanetaka, and W.N. Duran Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension American Journal of Physiology. Heart and Circulatory Physiology 292 2007 H2131 H2137
10. S.K. Kim, K.H. Jung, and B.C. Lee Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy Biological and Pharmaceutical Bulletin 32 2009 220 224
11. J. Lea, T. Greene, L. Hebert, M. Lipkowitz, S. Massry, J. Middleton, S.G. Rostand, E. Miller, W. Smith, and G.L. Bakris The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension Archives of Internal Medicine 165 2005 947 953
12. H.S. Lee, and S.K. Ku Effect of Picrorrhiza rhizoma extracts on early diabetic nephropathy in streptozotocin-induced diabetic rats Journal of Medicinal Food 11 2008 294 301
13. S.W. Leung, D.Y. Zhu, and R.Y. Man Effects of the aqueous extract of Salvia Miltiorrhiza (danshen) and its magnesium tanshinoate B-enriched form on blood pressure Phytotherapy Research 24 2010 769 774
14. G. Liu, G.J. Guan, T.G. Qi, Y.Q. Fu, X.G. Li, Y. Sun, T. Wu, and R.Z. Wen Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism Zhong Xi Yi Jie He Xue Bao 3 2005 459 462
15. S.M. Mauer, M.W. Steffes, E.N. Ellis, D.E. Sutherland, D.M. Brown, and F.C. Goetz Structural-functional relationships in diabetic nephropathy Journal of Clinical Investigation 74 1984 1143 1155
16. T.A. McGowan, Y. Zhu, and K. Sharma Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy Current Diabetes Reports 4 2004 447 454
17. K.M. Myint, Y. Yamamoto, T. Doi, I. Kato, A. Harashima, H. Yonekura, T. Watanabe, H. Shinohara, M. Takeuchi, K. Tsuneyama, N. Hashimoto, M. Asano, S. Takasawa, H. Okamoto, and H. Yamamoto RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin Diabetes 55 2006 2510 2522
18. F.P. Schena, and L. Gesualdo Pathogenetic mechanisms of diabetic nephropathy Journal of the American Society of Nephrology 16 Suppl. 1 2005 S30 S33
19. E.D. Schleicher, E. Wagner, and A.G. Nerlich Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging Journal of Clinical Investigation 99 1997 457 468
20. A.K. Sharma, and B.P. Srinivasan Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats European Journal of Pharmaceutical Sciences 38 2009 433 444
21. D. Suzuki, M. Toyoda, N. Yamamoto, M. Miyauchi, M. Katoh, M. Kimura, M. Maruyama, M. Honma, T. Umezono, and M. Yagame Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy Internal Medicine 45 2006 435 441
22. T. Umezono, M. Toyoda, M. Kato, M. Miyauchi, M. Kimura, M. Maruyama, M. Honma, M. Yagame, and D. Suzuki Glomerular expression of CTGF TGF-beta 1 and type IV collagen in diabetic nephropathy Journal of Nephrology 19 2006 751 757
23. X. Wang, S.L. Morris-Natschke, and K.H. Lee New developments in the chemistry and biology of the bioactive constituents of Tanshen Medicinal Research Reviews 27 2007 133 148
24. T.M. Wendt, N. Tanji, J. Guo, T.R. Kislinger, W. Qu, Y. Lu, L.G. Bucciarelli, L.L. Rong, B. Moser, G.S. Markowitz, G. Stein, A. Bierhaus, B. Liliensiek, B. Arnold, P.P. Nawroth, D.M. Stern, V.D. D'Agati, and A.M. Schmidt RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy American Journal of Pathology 162 2003 1123 1137
25. G. Wolf, R. Reinking, G. Zahner, R.A. Stahl, and S.J. Shankland Erk 1,2 phosphorylates p27(Kip1): functional evidence for a role in high glucose-induced hypertrophy of mesangial cells Diabetologia 46 2003 1090 1099
26. Y. Yamamoto, I. Kato, T. Doi, H. Yonekura, S. Ohashi, M. Takeuchi, T. Watanabe, S. Yamagishi, S. Sakurai, S. Takasawa, H. Okamoto, and H. Yamamoto Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice Journal of Clinical Investigation 108 2001 261 268
27. H. Yonekura, Y. Yamamoto, S. Sakurai, T. Watanabe, and H. Yamamoto Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury Journal of Pharmacological Science 97 2005 305 311
28. Y. Zhang, B. Chen, X.H. Hou, G.J. Guan, G. Liu, H.Y. Liu, and X.G. Li Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats Chinese Medical Journal 120 2007 988 995
29. G. Zhou, C. Li, and L. Cai Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway American Journal of Pathology 165 2004 2033 2043
30. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use Journal of Clinical Pharmacology 45 2005 1345 1359
31. F.N. Ziyadeh, and K. Sharma Overview: combating diabetic nephropathy Journal of the American Society of Nephrology 14 2003 1355 1357